Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sickle cell disease neonatal screening. First evaluation].

M Mbodj1, O Ndoye, M Diarra

  • 1Laboratoire de Biophysique et de Médecine Nucléaire-UCAD.

Dakar Medical
|March 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel 22bp deletion in a Tunisian phenylketonuria family.

Pathologie-biologie·2012
Same author

[Guidelines relative to the collection and handling management of biological samples].

Annales de biologie clinique·2011
Same author

[Guidelines concerning sample reception and request recording of laboratory tests].

Annales de biologie clinique·2011
Same author

[Management of pre-analytical nonconformities].

Annales de biologie clinique·2011
Same author

[Guidelines concerning stat laboratory process].

Annales de biologie clinique·2011
Same author

[Self assesment grid for pre-examination phase].

Annales de biologie clinique·2011

Neonatal screening for sickle cell disease in Senegal identified significant hemoglobinopathy rates (11.1%) in newborns. Early detection and management through screening programs can improve quality of life and life expectancy.

Area of Science:

  • Medical Genetics
  • Pediatrics
  • Public Health

Context:

  • Sickle cell syndromes pose a significant health burden, particularly in regions like Senegal.
  • Neonatal screening enables early diagnosis and intervention, crucial for improving outcomes in affected children.
  • A preliminary screening program was established for Senegalese newborns.

Purpose:

  • To assess the feasibility and prevalence of hemoglobinopathies in Senegalese newborns through a pilot screening program.
  • To evaluate the effectiveness of isoelectrofocalisation for neonatal sickle cell screening.
  • To provide data supporting the implementation of a national sickle cell neonatal screening program.

Summary:

  • The study analyzed 478 Senegalese newborns (aged 1-4 days) using isoelectrofocalisation on dried blood eluates.

Related Experiment Videos

  • Hemoglobinopathies were detected in 11.1% of infants: 9% with heterozygous FAS/FAC, 0.2% with FSC, and 1.9% with FSS.
  • These findings highlight the substantial prevalence of sickle cell disease and related conditions in the target population.

    • Impact:

    • Implementing a sickle cell neonatal screening program is crucial for early management, improving quality of life and life expectancy.
    • Integrating screening with information, training, and genetic counseling can help reduce homozygote births and disease spread.
    • Economic considerations support the imperative implementation of neonatal screening for sickle cell disease.